Spinal Cord Injury
📧 Sign up to get email alerts when something new happens for Spinal Cord Injury.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Sleep-Disordered Breathing in Chronic SCI [NA]
Clinical trial on sleep-disordered breathing in chronic spinal cord injury has completed; results posted in 2020.
-
FDA label_change · 2020-10-29FDA Approved: BACLOFEN — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for baclofen submitted by Chartwell RX, LLC.
-
FDA approval · 2020-10-22FDA Approved: TIZANIDINE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for tizanidine from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2020-10-09FDA Approved: BACLOFEN — Original Application (Method Pharmaceuticals LLC)
FDA approved an original application for baclofen from Method Pharmaceuticals LLC, making a generic version available.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: 24hr Effects of Tiotropium Bromide in Tetraplegia [Phase 2]
Phase 2 trial evaluating 24-hour effects of tiotropium bromide in tetraplegia due to spinal cord injury has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: The Effects of Spasticity on Glucose Metabolism in Individuals With Spinal Cord Injury
Completed clinical trial investigating how spasticity affects glucose metabolism in individuals with spinal cord injury; results posted in 2…
-
FDA approval · 2020-08-13FDA Approved: BACLOFEN — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Baclofen from Endo USA, Inc. (ANDA077068).
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: Ventilatory Support to Improve Exercise Training in High Level Spinal Cord Injury [NA]
A completed clinical trial investigating ventilatory support to improve exercise training in individuals with high-level spinal cord injury;…
-
CLINICAL_TRIALS trial_result · 2020-07-15Clinical Trial Update: Electrical Activation of The Diaphragm for Ventilatory Assist [NA]
Clinical trial update on electrical activation of the diaphragm for ventilatory assistance in spinal cord injury/quadriplegia patients; stud…
-
FDA approval · 2020-07-09FDA Approved: BACLOFEN — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved an original application for a generic baclofen product from Unichem Pharmaceuticals (USA), Inc.
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: Repeated Subarachnoid Administrations of hUC-MSCs in Treating SCI [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluated repeated subarachnoid administrations of human umbilical cord mesenchymal stem cells (hUC-MSCs) f…
-
FDA approval · 2020-05-27FDA Approved: TIZANIDINE HYDROCHLORIDE — Original Application (Trifluent Pharma, LLC)
FDA approved the original application for tizanidine hydrochloride from Trifluent Pharma, LLC as a generic drug.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Improving Functioning in Persons With Chronic Pain Post-SCI Through Virtual Classroom Education [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a virtual classroom education program aimed at improving functioning in people with chronic pain after spinal c…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Education Interventions for Self-Management of Pain Post-SCI: A Pilot Study [Phase 1, Phase 2]
A pilot study evaluating education interventions for self-management of pain after spinal cord injury, completed in Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: The Effects of Dexmedetomidine Dose on Motor Evoked Potentials [Phase 4]
Phase 4 clinical trial examining how different dexmedetomidine doses affect motor evoked potentials during spinal fusion, results posted aft…
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB [Phase 2]
Phase 2 trial evaluating the impact of probiotics on lower urinary tract symptoms in spinal cord injury patients has completed with results …
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Neural Adaptation After Tendon Transfer and Training in Tetraplegia [NA]
A completed clinical trial investigating neural adaptation after tendon transfer and training in individuals with spinal cord injury; result…
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Role of Enhancing Serotonin Receptors Activity for Sleep Apnea Treatment in Patients With SCI [Phase 2]
Phase 2 trial investigating serotonin receptor activity for sleep apnea in patients with spinal cord injury has completed with posted result…
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: Acute Effect of Ventilatory Support During Exercise in Spinal Cord Injury [NA]
A completed clinical trial evaluating the acute effects of ventilatory support during exercise in individuals with spinal cord injury; resul…
-
FDA approval · 2020-03-24FDA Approved: TIZANIDINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic version of tizanidine hydrochloride from Aurobindo Pharma Limited via Original Application (ANDA 213544) for the trea…
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Transplantation of Autologous Bone Marrow or Leukapheresis-Derived Stem Cells for Treatment of Spinal Cord Injury [Phase 2]
Phase 2 trial evaluating autologous bone marrow or leukapheresis-derived stem cells for spinal cord injury.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Home Neuromodulation of the Neurogenic Bladder in Chronic Spinal Cord Injury With Transcutaneous Tibial Nerve Stimulation [NA]
A completed clinical trial evaluating home-based transcutaneous tibial nerve stimulation for neurogenic bladder in individuals with chronic …
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: Timing and Dosage of Acute Intermittent Hypoxia in Persons With SCI [Phase 1, Phase 2]
Preliminary clinical trial update investigating timing and dosage of acute intermittent hypoxia in individuals with spinal cord injuries acr…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating intrathecal administration of expanded Wharton's Jelly mesenchymal stem cells in chronic traumatic spina…
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI [Phase 4]
Phase 4 clinical trial update investigating Botox for neurogenic detrusor overactivity and prevention of autonomic dysreflexia after spinal …